GP-Act III Acquisition Corp. (GPAT) vs Wen Acquisition Corp Class A Ordinary Shares (WENN)

A side-by-side comparison of GP-Act III Acquisition Corp. and Wen Acquisition Corp Class A Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — GPAT vs WENN

growth of $100 · dividends reinvested · last 1y
GPAT +5.4% (+5.4%/yr)WENN +1.3% (+1.3%/yr)GPAT compounded faster over this window
98100102104106Start $1002026$105$101
GPAT WENN

GPAT vs WENN: by the numbers

  • •GPAT is the larger company ($396M vs $391M market cap).
  • •WENN trades at the lower trailing earnings multiple (38.71 vs 45.54 P/E), one valuation lens rather than an overall verdict.

Metrics side by side

Valuation

MetricGPATWENN
P/E ratio45.5438.71
P/B ratio4.831.31

Profitability

MetricGPATWENN
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE10.30%3.62%
ROIC-2.32%-0.28%

Frequently asked

Which has the lower trailing P/E, GPAT or WENN?
WENN has the lower trailing P/E: GPAT trades at 45.54 and WENN at 38.71. P/E is one valuation measure and does not by itself establish which business is cheaper.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.